Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis
about
AVISPA: a web tool for the prediction and analysis of alternative splicingNintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosisSplicing Regulation: A Molecular Device to Enhance Cancer Cell AdaptationPosttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell BiologySplicing Regulators and Their Roles in Cancer Biology and TherapyPhosphorylation-mediated regulation of alternative splicing in cancerVascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic NephropathySerine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancerAlternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedPotential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)Expression analysis of an evolutionarily conserved alternative splicing factor, Sfrs10, in age-related macular degenerationAlteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training.The many faces of SRPK1TNF-α-induced ICAM-1 expression and monocyte adhesion in human RPE cells is mediated in part through autocrine VEGF stimulationPro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy.The anti-angiogenic isoforms of VEGF in health and disease.Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanomaVEGF-A165b is cytoprotective and antiangiogenic in the retinaA Comprehensive Analysis of CXCL12 Isoforms in Breast Cancer(1,2.)Vascular endothelial growth factor 165b expression in stromal cells and colorectal cancerAlternative splicing and retinal degenerationAntiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesityDo anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary taleVasculogenic mimicry of HT1080 tumour cells in vivo: critical role of HIF-1α-neuropilin-1 axis.Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization.The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapyAlternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance.Detection of VEGF-A(xxx)b isoforms in human tissuesChemical treatment enhances skipping of a mutated exon in the dystrophin gene.Ablation of SGK1 impairs endothelial cell migration and tube formation leading to decreased neo-angiogenesis following myocardial infarctionStress-responsive maturation of Clk1/4 pre-mRNAs promotes phosphorylation of SR splicing factor.VEGF spliced variants: possible role of anti-angiogenesis therapy.Alternative RNA splicing and cancerBalance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth.Tissue stiffness regulates serine/arginine-rich protein-mediated splicing of the extra domain B-fibronectin isoform in tumorsOvarian VEGF(165)b expression regulates follicular development, corpus luteum function and fertilityPro- and anti-angiogenic VEGF mRNAs in autoimmune thyroid diseases.VEGF165b overexpression restores normal glomerular water permeability in VEGF164-overexpressing adult mice.Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathyPost-transcriptional regulation in cancer progression : Microenvironmental control of alternative splicing and translation.
P2860
Q21183995-E0291510-97CB-46A1-9DB9-290B6CF9DD1DQ26783169-CF57B82C-672E-4824-A6B1-8DFC419E8454Q26798148-83553802-9636-4828-8993-F7AFB70F31E2Q26798154-710F1705-72E1-483E-94E4-62956D46CCD4Q26798158-40039F56-D4BB-450C-9032-8007EFC822E8Q27009883-AB659D6F-7B52-4C05-B12C-BFF9EF1220CBQ27342809-6B58C866-FC1B-472F-AF27-BDE69F03B511Q28251240-306608AF-8537-4E76-A057-75B8337979A5Q28297381-707748B4-6B8D-4FB4-931D-8680186FF221Q28547020-EEC1AD2B-9CBE-4339-A48E-06D1EF4C32BDQ28582788-1E51B285-24FC-40A7-A732-074AF85DC639Q30421761-5DDE6711-43BD-4AE1-A718-948E6F3AC2EBQ33364265-C2949727-5D0D-4FB9-BF21-33CA0847ED50Q33753821-861767F6-CC30-4387-BE7E-1716FAC84D5BQ33828636-23A3B90E-1CDB-4543-8EC6-17B9A6100494Q33901839-2C2DEFEB-CC1C-4229-BCF3-7DD7514202A5Q33994399-6684D490-82E1-4803-B49C-F5C4CD2A65F2Q34022623-77D304A6-734F-4771-ABA2-059E65F2841FQ34092009-4CDF530A-E010-460F-AB52-23ACC2654DE6Q34101611-191BC7E6-7705-4D08-9CF9-0671F8AD4B81Q34102442-933EA1BF-43CE-4459-BF33-98D0DD241520Q34244804-91DBD6DD-7CF4-465C-8153-E1AF5FA7BD92Q34261539-DAEE9466-57E3-439A-B496-74A92C49ED00Q34491119-ACDBC4B4-D2FC-4F48-88D6-DA36D4FCBB67Q34656053-64748C53-E8CC-4499-AEF7-2D36292F5B4BQ34792239-A8C1892F-1A4E-4F88-ABAA-D7A67BEC6512Q34854858-7A3507D2-1688-40A4-B692-0D59E0BCFC5BQ34918179-A86F0911-E03B-469A-902E-C8BF7BCB3723Q35039875-442BC69E-54D4-4602-904F-6954BCA67AE8Q35050584-229240B1-F353-4D1F-AC60-DD482D8D6B69Q35276828-6719444E-CF17-40BF-BCBC-7AF179115F24Q35369677-15E4977D-2991-4AE0-92B9-E66B7DC8F3B4Q35589667-57F4605A-4A57-49C5-AD20-1FEBB89B8BA7Q35780472-4E1CB70E-E2FA-4B45-BDD8-070B9688E71AQ35845913-821E9896-49F0-4A9F-A506-BC02538D8F4FQ35885946-6FBC103E-A17F-437D-BDAA-CD417315C8A6Q36095767-10A90DBA-77FD-40DC-B602-BB06CE61772DQ36312650-5F19A9C1-6253-43F1-B997-3DDC736AEFEEQ36379513-49DEFB51-0EE8-4F7F-A9FF-2758CE1D4071Q36398266-7BBB4623-96DF-468D-91EA-4F516167BF46
P2860
Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis
description
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2010
@ast
im Februar 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2010/02/19)
@sk
vědecký článek publikovaný v roce 2010
@cs
wetenschappelijk artikel (gepubliceerd op 2010/02/19)
@nl
наукова стаття, опублікована в лютому 2010
@uk
name
Regulation of vascular endothe ...... utic strategy for angiogenesis
@ast
Regulation of vascular endothe ...... utic strategy for angiogenesis
@en
Regulation of vascular endothe ...... utic strategy for angiogenesis
@nl
type
label
Regulation of vascular endothe ...... utic strategy for angiogenesis
@ast
Regulation of vascular endothe ...... utic strategy for angiogenesis
@en
Regulation of vascular endothe ...... utic strategy for angiogenesis
@nl
prefLabel
Regulation of vascular endothe ...... utic strategy for angiogenesis
@ast
Regulation of vascular endothe ...... utic strategy for angiogenesis
@en
Regulation of vascular endothe ...... utic strategy for angiogenesis
@nl
P2093
P2860
P3181
P356
P1476
Regulation of vascular endothe ...... utic strategy for angiogenesis
@en
P2093
Coralie Hoareau-Aveilla
Dawid G Nowak
Elianna Mohamed Amin
Emma S Rennel
Gopinath Damodoran
Masatoshi Hagiwara
Melissa Gammons
Michael R Ladomery
Steven J Harper
P2860
P304
P3181
P356
10.1074/JBC.M109.074930
P407
P577
2009-11-11T00:00:00Z